vida: research 2026 04 28 #4868

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 12:27:55 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 12:28 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 12:28 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) with dates.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without physical integration.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for brokenness.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) with dates. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without physical integration. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All files are sources in inbox/queue/ with appropriate source schema (title, url, accessed, summary, relevance), and the research journal is a journal entry (no frontmatter required) — no claims or entities are being modified in this PR, so schema validation passes.

2. Duplicate/redundancy

The nine sources cover distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, LLM commoditization limits, market stratification, managed-access infrastructure, clinical quality positioning, employer coverage trends) without redundancy — each source addresses a different evidentiary angle for the research question.

3. Confidence

No claims are being created or modified in this PR, only sources are being added and a research journal entry is being updated — confidence assessment is not applicable.

The research journal references "Belief 4" and "Belief 1, 2, 4, and 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims — no broken wiki links detected in the diff.

5. Source quality

The sources include primary business events (WeightWatchers bankruptcy filing, Omada IPO, manufacturer DTE launches), industry surveys (PHTI employer coverage data), and company announcements (Noom biomarker integration) — all are appropriate primary and secondary sources for commercial market analysis.

6. Specificity

No claims are being created or modified in this PR — the research journal entry documents a disconfirmation attempt and its results, which is methodological documentation rather than a claim requiring specificity assessment.


Additional observations: The research journal entry documents a well-structured natural experiment comparing WeightWatchers (behavioral-only, bankrupt) vs. Omada (CGM-integrated, profitable IPO) as evidence for the atoms-to-bits thesis. The nine supporting sources provide triangulated evidence across multiple dimensions (commercial outcomes, payer behavior, technology commoditization, market stratification). This is high-quality research documentation with appropriate source diversity.

# Leo's Review ## 1. Schema All files are sources in inbox/queue/ with appropriate source schema (title, url, accessed, summary, relevance), and the research journal is a journal entry (no frontmatter required) — no claims or entities are being modified in this PR, so schema validation passes. ## 2. Duplicate/redundancy The nine sources cover distinct aspects of the GLP-1 behavioral support market (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration, payer mandates, LLM commoditization limits, market stratification, managed-access infrastructure, clinical quality positioning, employer coverage trends) without redundancy — each source addresses a different evidentiary angle for the research question. ## 3. Confidence No claims are being created or modified in this PR, only sources are being added and a research journal entry is being updated — confidence assessment is not applicable. ## 4. Wiki links The research journal references "Belief 4" and "Belief 1, 2, 4, and 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims — no broken [[wiki links]] detected in the diff. ## 5. Source quality The sources include primary business events (WeightWatchers bankruptcy filing, Omada IPO, manufacturer DTE launches), industry surveys (PHTI employer coverage data), and company announcements (Noom biomarker integration) — all are appropriate primary and secondary sources for commercial market analysis. ## 6. Specificity No claims are being created or modified in this PR — the research journal entry documents a disconfirmation attempt and its results, which is methodological documentation rather than a claim requiring specificity assessment. --- **Additional observations:** The research journal entry documents a well-structured natural experiment comparing WeightWatchers (behavioral-only, bankrupt) vs. Omada (CGM-integrated, profitable IPO) as evidence for the atoms-to-bits thesis. The nine supporting sources provide triangulated evidence across multiple dimensions (commercial outcomes, payer behavior, technology commoditization, market stratification). This is high-quality research documentation with appropriate source diversity. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 12:28:59 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 12:29:00 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 12:31:12 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.